The tumor suppressor p53 plays a key role in regulating the cell cycle and apoptosis in differentiated cells. Mutant mice lacking functional p53 develop normally but die from multiple neoplasms shortly after birth. There have been hints that p53 is involved in morphogenesis, but given the relatively normal development of p53 null mice, the significance of these data has been difficult to evaluate. To examine the role of p53 in vertebrate development, we have determined the results of blocking its activity in embryos of the frog Xenopus laevis.
Background
Many mutant p53 alleles are oncogenic, and p53 was in fact first thought to be an oncogene as the first clones isolated corresponded to mutant forms expressed in immortalized cell lines. Expression of mutant p53 immortalizes primary fibroblasts, and in combination with mutant Ras transforms such cells [1] [2] [3] . Normal p53, however, functions as a tumor suppressor and its overexpression can inhibit the growth of various tumor cell lines and can block the transforming activity of a variety of oncogenes [4, 5] . The p53 protein possesses several different biochemical activities, including transcriptional activation and repression, binding to single-stranded DNA, and interaction with several heterologous proteins, (reviewed in [5] [6] [7] ). These activities regulate a diverse array of biological processes, for example cell cycle transitions, apoptosis, and response to DNA damage [5] [6] [7] . Elimination of p53 activity is thought to contribute to the initiation or progression of tumorigenesis by loss of cell cycle control, genomic instability, and the acquisition of novel properties, such as resistance to hypoxia [5] [6] [7] [8] . Given this involvement in numerous fundamental processes, it is quite surprising that p53 null mice develop to term in the majority of cases [9] [10] [11] . However, p53 is expressed during early murine development in a pattern consistent with a role in differentiation [12] [13] [14] [15] , and the precise regulation of expression appears to be essential for normal development [16, 17] .
Observations from transgenic mice and tissue culture experiments raise the possibility that p53 may be required for normal differentiation in some cell types. Foremost among these observations is the high incidence of neural tube and craniofacial abnormalities observed in p53 null mice in some genetic backgrounds [10, 11] . Furthermore, transgenic mice are under-represented in the offspring of transgenics expressing mutant p53 [18] . Other in vitro observations consistent with a developmental role include a possible requirement for p53 in hematopoiesis [19, 20] , muscle differentiation [20] , and neural differentiation [21, 22] . The possibility of a role for wild-type p53 in early development has been the subject of recent reviews by Hall and Lane [23] and Rotter et al. [24] . These data suggest that either p53 has an essential role in some aspect of differentiation, or that the lack of p53 activity results in the rapid accumulation of genetic lesions, which in turn inhibit normal development. In order to investigate the function of p53 during early embryogenesis, the activity of the p53 protein was inhibited in a simple model system useful for investigating vertebrate development, the Xenopus embryo. The very rapid development of this animal allows the requirement for this protein during embryogenesis to be analyzed with little or no chance of genetic damage playing a role.
Xenopus p53 is biochemically similar to human p53 [25] , and Xenopus embryos contain a ubiquitous maternal stockpile of p53 mRNA and protein [26, 27] . Elimination of protein function in Xenopus has been most effectively achieved by overexpression of dominant-negative mutants [28] [29] [30] [31] , and many mutant forms of p53 have been shown to act in a dominant-negative manner, (for example [32, 33] ). To examine the role of p53 in early Xenopus development, synthetic mRNA encoding various dominant-negative forms of human p53 was microinjected into early Xenopus embryos. As some mutant p53 proteins have been reported to have subtle gain-of-function activities in addition to the ability to block the function of wild-type p53 in a dominant-negative manner [34] , the activity of p53 was also inhibited by overexpressing Xdm-2, the Xenopus ortholog of the murine double minute-2 (mdm-2) gene, which encodes a negative regulator of p53 activity [35] [36] [37] [38] . The result of inhibiting p53 activity by either of these approaches was the same: differentiation was blocked. Cells expressing either mutant p53 or Xdm-2 continued to divide at approximately normal rates but failed to differentiate and remained as cell masses, or tumors. These data indicate that p53 activity is essential for differentiation in Xenopus.
Results and discussion

Dominant-negative p53 induces the formation of developmental tumors
In order to inactivate the maternal stockpile of Xenopus p53, synthetic mRNA encoding a dominant-negative form of human p53, p53 Thr280 [39] , was microinjected into a single blastomere in the presumptive mesoderm of 32-cell stage embryos along with mRNA encoding nuclear β-galactosidase as a lineage tracer [40] . Injected embryos were then raised to tadpole stages, fixed, and stained for β-galactosidase activity (Figure 1a) . Injection of β-galactosidase mRNA alone had no effect on development (Table 1) , and in such control experiments, β-galactosidase-positive cells were found evenly incorporated into axial structures ( Figure 1a ). However, in embryos co-injected with p53 Thr280 mRNA, the β-galactosidase-positive cells derived from the injected blastomere were found to be clustered into large cell masses, with no organization into axial structures ( Figure 1a and Table 1 ). Cell masses were most obvious at the late tailbud stage. These cell masses often persisted through to feeding tadpole stage, although diminished in size, without becoming incorporated into tissues. As injected mRNAs are only stable in Xenopus embryos until neurula stages [41] , the cell masses persist long after the mutant p53 mRNA which led to their formation has been degraded. It is possible that the undifferentiated cell masses miss the temporal window when cells are competent to differentiate or when the embryonic signals triggering differentiation are present.
Histological analysis revealed that the cell masses formed by cells expressing p53 Thr280 resembled tumors in a number of ways. The cell masses were nucleated and the cells within them were of approximately normal size and retained large numbers of yolk platelets, reminiscent of undifferentiated cells (Figure 1b,c) . Furthermore, abnormal nuclear morphologies were observed (Figure 1d ), and the cell masses were sometimes surrounded by an epithelial capsule and were often adjacent to large deposits of extracellular matrix. Many tumors had associated melanocytes, either superficial or integrated (Figure 1b,c) . Figure 2 ) was used to score the frequency of tumor formation, and tumor phenotypes were confirmed by histology. p53 His175 was not cloned into the expression vector 64TS and mRNA was generated from pBS (see Materials and methods); such mRNA will have a significantly lower translational efficiency [40] , which may explain the reduced frequency of tumor formation for this mutant. β-gal, β-galactosidase; Xp53, Xenopus wild-type p53; Hp53, human wild-type p53; xWT1, Xenopus wild-type WT1 [71] .
As these tumors are derived from embryonic cells that have failed to differentiate, rather than from cells that have undergone dedifferentiation, they can be classified as blastomas, or undifferentiated embryonic-derived tumors.
Blocking p53 activity did not overtly interfere with or promote cell proliferation. As Xenopus early development proceeds without growth, cell division results in the formation of smaller and smaller cells with each cell cycle. When a single blastomere was injected with mutant p53, it gave rise to tumors containing hundreds of cells of approximately normal size (see Figure 1) shown), extensive apoptosis was not triggered by blocking p53 activity, as evidenced by the low frequency of such pycnotic nuclei and the continued presence of β-galactosidase-positive tumor cells. Although low levels of p53 block apoptosis in some systems [42, 43] , pycnotic nuclei are not commonly observed in normal Xenopus embryos at this stage of development; the mutant p53 is thus unlikely to be leading to tumor formation by blocking the low level of normal apoptosis. These observations indicate that the formation of tumors is not likely to be the result of proliferative or apoptotic defects, but rather is the result of the failure of cells to be incorporated into normal tissues and to undergo differentiation.
When embryos were injected into the presumptive somitic mesoderm, cells expressing a dominant-negative p53 were often displaced dorsally and lay adjacent to the neural tube just below the epidermis (Figure 1b ,c). In many instances, such tumors were integrated into the adjacent differentiated epidermis or neural tube. However, these cells did not take on the morphology of neural or epidermal epithelial cells (Figure 1b ,c). In many cases where tumors were found lateral to the neural tube, the somite on the injected side of the embryo was restricted ventrally and greatly reduced in size ( Figure  1b ). This reduction of the somite may be a result of tissue distortion caused by the presence of the tumor, but is more likely due to the failure of p53 Thr280 -expressing cells to differentiate and consequent failure of these cells to contribute to the somitic tissue. Tumors were also, though more rarely, found associated with mesodermal tissues such as somite and pronephros ( Figure 2 ).
The phenotype elicited by mutant p53 was not due to non-specific effects caused by mRNA toxicity, as overexpression of wild-type human or Xenopus p53 never induced tumor formation or inhibited normal differentiation (Table  1) . Although it has been reported that overexpression of wild-type Xenopus p53 results in cell cycle arrest [26] , the doses required to elicit such effects were extremely high, the lowest dose being more than double the highest dose injected here. In this study, injections of up to 1 ng of Xenopus or human wild-type p53 never elicited cell cycle arrest or tumor formation. Likewise, injection of β-galactosidase mRNA alone, even at very high doses, had no effect on development (Table 1) . Furthermore, no tumors have been reported in Xenopus embryos in previous studies in which other gene products were ectopically expressed, including other tumor suppressor genes such as APC [44] and WT1 (Table 1) , proto-oncogenes such as jun [31] and ras [45] , viral oncogenes such as polyoma middle T [46] and v-ras [45] , or cyclins such as cyclin B2 [47] .
Dominant-negative p53 inhibits differentiation
Histological analysis revealed that cell masses expressing dominant-negative p53 appeared to be undifferentiated (Figure 1 ), and p53 has been suggested to be involved in the differentiation of a number of cell types in vitro [19] [20] [21] [22] [23] [24] . We therefore used immunohistochemistry to determine if elimination of p53 activity inhibited differentiation in vivo in the developing Xenopus embryo.
The p53 Thr280 mRNA was co-injected with β-galactosidase mRNA into blastomeres fated to give rise to brain and spinal cord (Table 2) . At tadpole stages, cells that stained positive for β-galactosidase (and therefore expressed p53 Thr280 ) and were associated with the neural tube were analyzed for the expression of markers of neural differentiation using wholemount immunohistochemistry. Such tumors failed to stain with antibody XAN3/6F11 ( Figure  3a) , an early marker of neural cells [48] . Likewise, tumors did not stain with antibody 2G9, which detects terminally differentiated neurons (Figure 3b ). p53 Thr280 mRNA was then co-injected with β-galactosidase mRNA into presumptive somitic blastomeres (Table 2) . Tumors adjacent to embryonic somites failed to stain with either of two Some evidence has suggested that p53 may be involved in the differentiation of the kidney [50, 51] . p53 Thr280 mRNA was therefore injected into blastomeres that give rise to the kidney, and development of the kidney was assayed with the pronephric tubule-specific antibody 3G8 [52] . p53 Thr280 expression completely inhibited the differentiation of pronephric tubules (Figure 3e ,f).
In summary, targeted delivery of mutant p53 induced tumor formation and inhibited differentiation in blastomeres fated to give rise to epidermis (Table 2) , neurectoderm and mesoderm ( Figure 3 and Table 2 ), indicating that p53 activity is required for differentiation in most, if not all, Xenopus cell types.
Wild-type p53 suppresses the tumor-inducing activity of mutant p53
Although mutant human p53 was overexpressed in these experiments, Xenopus p53 is similar in structure and function to human p53 and can form functional heterotetramers with human p53 [25, 53] . If the mutant p53 blocks differentiation by oligomerizing with and inhibiting the activity of the endogenous Xenopus p53 protein, the effect should be abrogated by co-injection with excess wild-type p53. Indeed, when an excess of either human or Xenopus wildtype p53 was coinjected with p53 Thr280 , the frequency of The blastomeres were injected with 500 pg of p53 thr280 mRNA plus β-galactosidase, raised to tadpole stages, and scored for tumor frequency. Mutant p53 blocks the differentiation of blastomeres fated to form somite, kidney, brain, spinal chord and epidermis. Blastomere numbering and prospective fates are according to Dale and Slack [72] .
tumor formation was dramatically reduced (Figure 4 ). Considering that p53 functions as a tetramer, most oligomers formed from a 4:1 mixture of wild-type to mutant p53 protein will contain at least one mutant subunit. This fact, in addition to the enhanced stability of mutant p53 proteins [54] [55] [56] may explain the inability of wild-type p53 to completely rescue the tumor phenotype. Due to dosage constraints, greater amounts of wild-type mRNA could not be tested.
Different p53 mutants elicit a similar developmental phenotype
It is possible that the tumor phenotype was the result of an activity unique to p53 Thr280 . Therefore, the activity of other p53 dominant-negative mutants was evaluated using identical protocols. The original mutant tested, p53 Thr280 , disrupts an essential base contact in the DNA-binding domain [39, 57] . Another mutant, p53 Trp248 , disrupts DNA binding by eliminating essential minor groove contacts [57] . Expression of p53 Trp248 elicited a tumor phenotype identical to that of p53 Thr280 in terms of frequency (Table  1) , size, gross morphology, and histology ( Figure 5) . A third mutant, p53 His175 , which disrupts protein folding in the DNA-binding domain [57] , also elicited a similar tumor phenotype ( Figure 5 and Table 1 ).
Ectopic Xdm-2 induces developmental tumors
The observation that wild-type p53 protein can block the activity of a mutant protein and that three different p53 mutants induce similar tumors argues that the mutant human p53 proteins block differentiation by inhibiting the activity of endogenous Xenopus p53. It is possible, however, that these different proteins possess a common gain-of-function (neomorphic) activity and act via other proteins not normally associated with wild-type p53. We therefore sought to repress p53 activity without introducing mutant human proteins.
The mdm-2 gene encodes an oncoprotein which binds to and inhibits the activity of the p53 transcriptional activation domain [35, 36] and targets p53 for ubiquitin-mediated degradation [37, 38] . In order to eliminate p53 activity, mRNA injection was used to overexpress the Xenopus ortholog of mdm-2, Xdm-2 [35] , in developing embryos. The expression of Xdm-2 during normal Xenopus development has not yet been described; however, the developmental expression of this gene is not relevant to the experiments described here, as microinjected Xdm-2 was used only to interfere with the maternal stockpile of p53, not endogenous Xdm-2.
Overexpression of Xdm-2 mRNA elicited a tumor phenotype quite similar to that of mutant p53 ( Figure 5 ), although at a lower frequency (Table 1) . These tumors were again identified initially by the failure of β-galactosidase-positive cells to incorporate normally into axial structures of the embryo (not shown). Tumors resulting from Xdm-2 overexpression were in general smaller than those elicited by mutant p53; however, histological analysis revealed that Xdm-2-induced tumors were similar in morphology to those resulting from mutant p53 expression ( Figure 5 ). Xdm-2-induced tumors tended to be located in aberrantly dorsal positions, contained yolk-filled, nucleated cells, and were sometimes integrated into the neural tube or epidermis (Figure 5d ).
It is possible that Xdm-2 induces tumors at a lower frequency than mutant p53 because of differences in protein stability, stoichiometry of inhibitory mechanisms, or because Xdm-2 possesses only a subset of the activities of mutant p53. Xdm-2 may induce tumors by blocking endogenous p53 activity, while mutant p53 proteins may function both by blocking endogenous p53 and by gainof-function activities [34] . The early lethality observed in mdm-2 null mice can be rescued by generating such mice in a p53 null background, arguing that the only essential function of mdm-2 during normal development is the regulation of p53 activity [16, 17] . Given this observation, it would seem that the Xdm-2 induced developmental tumors represent the minimal consequence of blocking p53 activity in Xenopus. A quantitative biochemical analysis of the effects of Xdm-2 and mutant p53 on the transcriptional activity of endogenous p53 will be required to explore this issue.
Mutant p53 does not interfere with the mid-blastula transition
In Xenopus embryos, the first 12 cell cycles do not contain G1 or G2 phases; the cell cycle acquires these phases only after the mid-blastula transition (MBT), concomitant with the onset of zygotic gene expression and the loss of cell cycle synchrony [58, 59] . One possible role for p53 in early amphibian development could be to implement G1 and G2 cell cycle control at the MBT. In order to examine this possibility, the MBT was analyzed in embryos injected with p53 Thr280 into all cells at the four-cell stage. Zygotic transcription was activated normally (Figure 6 ) and the cell cycle became asynchronous at the MBT in embryos expressing p53 Thr280 in all cells (not shown), indicating that the MBT occurred normally. Not only does general transcriptional activation commence normally, as indicated by the activation of a housekeeping gene, EF-1α [60] , but mesodermal gene expression also commences normally, as evidenced by the activation of Brachyury [61] and goosecoid [62] expression. This indicates that the mutant p53 is not blocking mesoderm induction. Rather, mutant p53 seems to be acting by blocking cells' ability to act on these signals and differentiate into mesoderm.
The p53 protein contains a negative regulatory domain in its carboxyl terminus; when this domain is unphosphorylated, the transcriptional activation activity of p53 remains Research Paper p53 activity is essential for normal development in Xenopus Wallingford et al. 753 latent [63] . The observation that inhibition of p53 activity does not affect cleavage (not shown) or the MBT ( Figure  6 ) suggests that the maternal stockpile of p53 protein in the Xenopus embryo [26, 27] may remain inactive and play no part until after the MBT, when embryonic cells begin to differentiate. This hypothesis is consistent with the finding that functionally inactive p53 protein in teratocarcinoma cells is activated upon differentiation [64, 65] .
A role for p53 in development
Taken together, these results suggest a crucial role for p53 in early Xenopus development. Although dominant-negative p53 mutants may have gain-of-function activities, the fact that Xdm-2 elicits a strikingly similar phenotype argues that the mutant proteins are likely to be acting by interfering with endogenous p53. If a gain-of-function activity is responsible, this activity must be shared by three different mutants and a distinct tumor phenotype must be elicited by ectopic Xdm-2. Although this would be an extraordinary coincidence, we are performing experiments to eliminate this possibility by interfering with p53 activity by other means and by examining the effect of mutant p53 and wildtype Xdm-2 on the biochemical activity of embryonic p53. The most likely explanation for the data presented here is that p53 activity is essential for normal development in Xenopus, and that interfering with p53 function results in blocking the ability of embryonic cells to differentiate.
How can p53 be essential to frog development but largely dispensable during murine development? One possibility is that p53 is required for a developmental process that is not utilized during murine development. The mostly likely candidate process would be the mid-blastula transition, which is critical to frog development but has no true equivalent in mice. The data shown in Figure 6 indicate, however, that the MBT occurs normally and so cannot explain the incongruence between mouse and frog observations. The Xenopus embryonic cell cycle undergoes a second transition period a few cycles after the MBT. This second transition is known as the early gastrula transition (EGT) and is characterized by a significant lengthening of the gap phases of the cell cycle [63] . This lengthening may reflect the acquisition of additional checkpoints or other cell cycle properties, and these additional properties may be essential for differentiation. The timing of the EGT is consistent with the defects observed in response to blocking p53 activity, as the first stages at which defects have been identified are early neurulae, shortly after the end of gastrulation.
Xenopus embryos contain a large maternal stockpile of p53 mRNA and protein [27] , and murine teratocarcinoma cells are known to contain a stockpile of inactive p53 protein that is activated in response to differentiation signals [65] . However, mammalian embryos express only low levels of p53 [12] and maternal stocks of p53 have not been described. Furthermore, a maternal stockpile of p53 protein in p53 null mice cannot explain the lack of an early effect on mouse development, as p53 null mice can be crossed and produce viable offspring [10] . It is possible that the Xenopus stockpile is utilized for some as yet uncharacterized, but essential, aspect of differentiation. A temporal analysis of the DNA-binding and transcriptional activating activity of this stockpile may help to define the process(es) for which it is required.
Another possibility is that mice have genetic redundancies not present in frogs, making Xenopus more sensitive to p53 inhibition. For example, in mammals, mutation of MyoD or Myf-5 does not disrupt myogenesis, but combination of the two mutants does [66] . The detailed analysis of MyoD mutants alone would not have predicted a role for this important gene in muscle development. Other useful examples are the activins, which seem to be essential for mesoderm induction in Xenopus [28] but not for mesoderm formation in mice [67, 68] . Once again, excluding a role for this gene in development solely on the basis of the mouse mutant phenotype would have been premature. Lower vertebrates may have less complex redundancies protecting proliferation and differentiation, making them more dependent on p53 function. It is interesting to note that developmental defects in p53 null mice occur at different frequencies in different genetic backgrounds [10, 11] , implying that at least some such functional redundancies exist, and that without these redundancies p53 function is necessary for normal development. This hypothesis is further supported by evidence from cultured mammalian cells. For example, elimination of p53 activity inhibits differentiation of at least two different hematopoietic lineages [19, 20] . Furthermore, dominant-negative p53 inhibits the differentiation of primary cultures of mammalian neurons [21] . Expression of dominant-negative p53 also inhibits the differentiation of cultured mammalian myoblasts [20] . These observations are consistent with our data indicating that inhibition of p53 activity blocks the differentiation of neural and muscle tissue (Figure 3) . The elimination of p53 activity in various cell lines inhibited differentiation without altering the cell cycle [20] , a result consistent with our in vivo observations in Xenopus embryos in which differentiation was also blocked without overtly affecting proliferation. Together these data indicate a new biological role for p53 as a regulator of cell differentiation in vertebrates.
The commonly used p53 Val135 transgenic mice express a rather weak temperature-sensitive mutation under the control of the p53 promoter [18] . As mutant proteins must be present in excess to interfere effectively with wild-type protein [6] , these mice may not really address the question of a role for p53 in development. High-level expression of a potent dominant-negative p53 mutant protein during early murine development may well have more penetrant effects than targeted p53 disruption, especially if mutant proteins possess a weak gain-of-function activity in addition to their dominant-negative activity. We are examining the activity of p53 Thr280 on very early murine development to explore this issue. If the existence of genetic redundancies is the reason for the lack of a penetrant phenotype in p53 null mice, the lack of such redundancies in Xenopus may provide a system in which the redundant genes can be identified. Microinjection of mutant p53 mRNA plus pools of mRNAs from mammalian cell lines into Xenopus embryos and screening for the ability of such pools to suppress tumor formation may allow the identification of the redundant genes. If such genes exist, their identification will be relevant to the study of human tumorigenesis.
Given that investigations into the developmental role of p53 in two organisms -mice and frogs -have produced different conclusions, it is of interest to know which result is the more typical of vertebrates. 
Conclusions
Blocking p53 activity by ectopic expression of mutant p53 protein or by wild-type Xdm-2 inhibits differentiation without overtly interfering with cell division or early zygotic gene expression. This block to differentiation can be suppressed by wild-type p53. These results indicate that p53 activity is essential for normal development in Xenopus, providing an important counterpart to the observation that loss of p53 activity is so intimately associated with the reverse process -loss of differentiation.
These results show the usefulness of this embryonic system for evaluating the biological activity of mutant p53 genes. Despite the wealth of knowledge of p53's biochemical activities and how this protein is modified in human cancers, it is still not clear how mutant p53 proteins contribute to the initiation or progression of cancer. The system described here will provide a sensitive, simple and rapid assay for evaluating the activity of p53 mutants in both embryogenesis and tumorigenesis, without the inherent problems of genomic instability observed in transgenic animals and cultured cells. By studying a single, reproducible and penetrant activity on early development rather than the complexities engendered by the unique nature of each transformation event in mammalian tumors, we may be able to progress towards understanding the key role of this protein during both differentiation and dedifferentiation.
Materials and methods
Constructs and injections
Mutant and wild-type p53 cDNAs, and Xdm-2 cDNA, were subcloned into the Xenopus expression vector pSP64TS, which provides Xenopus globin 3′ and 5′ untranslated regions that significantly improve translation efficiency, with the exception of p53 His175 , which was used in pBS-SK (Stratagene). Capped mRNA was transcribed in vitro [69] , and embryo handling, microinjections (2-5 nl) and β-galactosidase assays were performed as previously described [40] with the exception that fixation prior to β-galactosidase development was performed using MEMFA (0.1 M MOPS, pH 7.4, 2 mM EGTA, 1 mM MgSO 4 , 3.7% formaldehyde) for 25 min only. Embryos were staged according to Nieuwkoop and Faber [70] .
Immunohistochemistry and histology
Embryos were fixed in MEMFA, stained for β-galactosidase activity [40] and processed in one of two ways. Some specimens were stained for antibodies 2G9 or XAN3/6F11 (neural), 12/101 or 5A3 (muscle), 3G8 (pronephros), or EPA (epidermis) using whole-mount immunocytochemistry, embedded in JB-4 (Polysciences), sectioned at 5 µm, and counterstained with Sytox™ green (Molecular Probes) or hematoxylin and eosin (Sigma). Other specimens were embedded in Paraplast, sectioned at 10 µm, and stained with antibodies using serial-section immunochemistry. This procedure yielded better penetration of the antibody into the specimens.
RT-PCR
Embryos were injected with 0.5 ng p53 thr280 into the marginal zone of all four cells at the four cell-stage; control embryos were uninjected.
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Total RNA was extracted from five embryo equivalents at stages 6, 10.5, and 13 and reverse transcribed. The polymerase chain reaction (PCR) was performed using one tenth of each reverse transcription reaction, Taq polymerase, 1 µCi of 32 P-dATP, and primer sets listed below; cycle temperatures were 92°, 55°, and 72°; EF-1α for16 cycles; goosecoid and Brachyury for 19 cycles. Primer sets were as follows: EF-1α: CAGATTGGTGCTGGATATGC and ACTGCCTTGATGACTCCTAG; goosecoid: ACAACTGGAAGCACTGGA and TCTTATTCCAGAG-GAACC; Brachyury: GGATCGTTATCACCTCTG and GTGTAGTCTG-TAGCAGCA. One fifth of each PCR reaction was then electrophoresed on a 5% non-denaturing acrylamide gel and autoradiographed.
